(Q41707776)
Statements
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team (English)
R Haubrich
M Thompson
R Schooley
W Lang
A Stein
D Sereni
M E van der Ende
D Richman
G Pagano
L Kahl
A Fetter
D J Brown
1 December 1999